{"name":"Upsher-Smith Laboratories","slug":"upsher-smith-laboratories","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Qudexy XR","genericName":"Qudexy XR","slug":"qudexy-xr","indication":"Epilepsy (seizure prophylaxis)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"USL255","genericName":"USL255","slug":"usl255","indication":"Atrial fibrillation for stroke prevention","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Vogelxo","genericName":"Vogelxo","slug":"vogelxo","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Qudexy XR","genericName":"Qudexy XR","slug":"qudexy-xr","phase":"marketed","mechanism":"Qudexy XR is an extended-release formulation of topiramate that enhances GABAergic inhibition and blocks sodium channels in the central nervous system to reduce neuronal excitability.","indications":["Epilepsy (seizure prophylaxis)","Migraine prophylaxis"],"catalyst":""},{"name":"USL255","genericName":"USL255","slug":"usl255","phase":"phase_3","mechanism":"USL255 is a small molecule that acts as a selective inhibitor of the sodium-activated potassium channel, Nav1.5.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"Vogelxo","genericName":"Vogelxo","slug":"vogelxo","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPNUt3bDltQ09OaWRyRktsM3ZXQVplVTVSeVl5TkE4YnVBUnA4d1NYX1FXWHJhb1pSay1wLXdMMldEMnZ5eEc1MkNzemEtNE14d0p4OE5kTjQwdEtYaVphSmIzY0FCUVB3LXBBQXlhVzdGdHNEdjgtZ25mSUlFR2FnUmZaZkRZa0RxR1FCb0ZLVzdZb3ZuUXJsdDhDRTkwWUNZcjdmdVRnOF9LUkZoY3hxMklFbTZEWDhLbFN6bHBYNTZ6Z3dFamxpMVZMVXViVThrejZmMmk4M0JxcmZiY21ZY2F0X2tmSzd6?oc=5","date":"2026-04-07","type":"patent","source":"BioSpace","summary":"UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION - BioSpace","headline":"UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPbGpJeWhCSTFqbURzZlB5SmdJeDFYQ1E4TWNaUWQyNHM2TS1zR2VHS0FaNm0ybVRndi1IcHh4V2UxdE43VUtraXNZNUQtel81YlZSVnh3cl9udUthVG9UZDFJeTE0WnFUbUtxekFZVzc5UmZjdUQ2eXZ1RkdUSHNzbktJNXI5b1VLRWlPckdpVnQzdFNwV2p2UmtrTkRlamxSMThr0gFaQVVfeXFMT2x5dFF2MnJiRHdLdExBc3BQeXY5Vld1bWNjRUV5Q0o3M0VhcjM5N1lXQmZCSFFveFllQ1Zkc0JsR0xGdExtT1FaTHBncF9NdmFPOFkzSlVKSXBn?oc=5","date":"2026-01-28","type":"pipeline","source":"MLex","summary":"End-payers drop claims in US Dexilant antitrust litigation - MLex","headline":"End-payers drop claims in US Dexilant antitrust litigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOTTJSd3NYVHFyYldtSzdkTy1FSWxrQkFnWTBsZnNFTlVfcHZZSGczLVl4dW02dGFtTW03UTlPdzhjT2w0d1o4NGFFdW9NQkFrQVVoRmRZdlpJb1VWNGZqXzU5YkpvOWFJYUE2UHBIOWs3NVk0aHI4ZmdSYmdCZ2kzcXV0b2V5Mjl5UmtwbzJNMHhTZ1ZUcHZNblVLTTRLQ19ScHRFdXhVaVQtU09DNnc?oc=5","date":"2025-12-02","type":"pipeline","source":"specialtypharmacycontinuum.com","summary":"Kymbee Deflazacort DMD Treatment - specialtypharmacycontinuum.com","headline":"Kymbee Deflazacort DMD Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOTXhWVzBNVlIyLW94dmRBQlYyM2VudTFEZFh5Mm5DUlVDdmRfb1R2MFhnd3NJWUhCN1lUWWx2SHBKN1dIbGxCeTdrTmdzd3ZqdmRSTkpsSy13U3U4U2MyTlFfN2UyMUV1aE9nSXREYmVwVVkxZGFoc1Fpa2ROS1lzYkFEd3c2MV9YblRoaFBiLTc3WlgxWmlobEoyT0VHZDdtN3hLaVhlU0pJUUFIN1NOUGpDYnFmVUpBMERyTnNB?oc=5","date":"2025-09-10","type":"pipeline","source":"Fierce Pharma","summary":"Takeda faces another 'pay-for-delay' antitrust lawsuit, this one from CVS over heartburn drug Dexilant - Fierce Pharma","headline":"Takeda faces another 'pay-for-delay' antitrust lawsuit, this one from CVS over heartburn drug Dexilant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQRzkwZFgtMGJoaGxoNWd4Um5tYWVEYkIwZVJCcXJEeU5QdGViUWRvOEdtcHF5ZnRMdkN2UHM0TG03dkNIX3Y4dlBoQzBrZXpNU2g4a3BPWjd3cDZvRjZncmM0ZmN0aTBmY0xhLWxPZWo5dTFMZEJtQ3JXTUFKSGcwekdfSFFvRU55T1RuMkFoUmFaQQ?oc=5","date":"2025-08-07","type":"pipeline","source":"PharmTech.com","summary":"Bora Pharmaceuticals to Expand Midwest Manufacturing Site - PharmTech.com","headline":"Bora Pharmaceuticals to Expand Midwest Manufacturing Site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQMWNXZzduaU1KZGRmTGpScDJfSUlRSUVHTi14a0dMeGdaanpLanItOGw4eXhsR1J3anRIQkRVdEdPSkpZR2plVDVzX014bVFjeWZ0NHBVMXZObXg0Zk1XZ0k4QVphWkZRMjBOc0RPeW9HQUIyVDNTekRBRUZ1UUsxbkFiR3dNTVJ1M3lkZF9ESWo1ZGF5Q0E4VGR5X0hVMHJ3VjllSXV2dE11aHlxZ0UzMkxlWGVGbUpVSFlRRUM0UmtOZw?oc=5","date":"2025-08-07","type":"pipeline","source":"MinneapoliMedia","summary":"Bora Pharmaceuticals Announces Major Expansion Of Maple Grove Plant - MinneapoliMedia","headline":"Bora Pharmaceuticals Announces Major Expansion Of Maple Grove Plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPVWctdnJHN2Z2MjhXSzBDXy0teFQ3YTZWN2t6NmVnLW9WTEpxelBPMGp6SjlyRXc3VTNxdU45Uk0yNXlqdkFXMENGOU51RjQzbzlRanN4NHY0VjEtMTdKdkJwaUZEYm5rTW1tdVkyaVFvdkJrTmY3R2VkQzZTNmFVUzg1UmkxZi1OQ0xCVTZEbGVsYVVpbTlQWjcxd1M?oc=5","date":"2025-08-07","type":"pipeline","source":"Manufacturing Chemist","summary":"Bora Pharmaceuticals announces multi-year expansion for midwest manufacturing site - Manufacturing Chemist","headline":"Bora Pharmaceuticals announces multi-year expansion for midwest manufacturing site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNMzk4dU1sdHI2TDBkX0xkVW5mMlN5V0trTlFnamNnc0o0a1ByUTYydGE1dUhVXzcxX0t2OWt1M1gtcW5iLU1Jb0Fwa1ZncU85Zm4wWDBFcUJfdjBMNzJYZmppV2FwaWtOTHJ3d3ZDVHhfQWo4YlBxTUZCcnN0M1N3MmM3bElZRVJhTVZlSlFxUWpuY0o3Z1RTejZQVF9wNGRiNGFlVw?oc=5","date":"2025-08-06","type":"pipeline","source":"The Business Journals","summary":"Bora Pharmaceuticals to expand Maple Grove facility with 100,000-square-foot buildout - The Business Journals","headline":"Bora Pharmaceuticals to expand Maple Grove facility with 100,000-square-foot buildout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxONzhHZ3hJQUdMd0dDVFFrLVUybUNWQk9helpiUnR2UkhXdW5PZ19yVjFRdmw1VkppNDhkQmplS3QwRExoNnV0RWlvTXR3WkpQOHB6S3F6aVlmWk1LdFZmeG04X2xKZFJpazBSSllUb0JQSHBrSXRZT3loSGxFeHhHMVJwTTBhUFBHNHJaWW1sUG9heXF4bnctYng1YmNFdW5PakpUR1c0Q3AxblhSYmpRcDRueEFaUV9VeXo0WGhSOXFJZnBhNXhWMzlxd0prdnpWWTlWVHBVVllpZFJmUURjNk9haXBfc1ExcDFybU1MVWxub0FCSHBR?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"Bora Pharmaceuticals Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Split is Finalized - BioSpace","headline":"Bora Pharmaceuticals Announces Multi-Year Expansion for Midwest Manufacturing Site, as Upsher-Smith Entity Split is Fina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxNTmt3elI5UU01b0lkNy12WkYyNVRUdy02MUR6ZUphY0Z6VnBPU0h5aVFrb0JDcFd5UUJJWl9nTWZLd0JDOG44dDN2R2lnSG5QTHdPNTlLa2c1REFxUFkyb0d3R3BoNFhaTHlrWDg1c1RFVWxfc0VyaGFQcWZGa3F3RFZvTVdIQzhMbGxzU285Q0FoUzBFZXNvQ2diaEp6emRyb2tZMnlKbW5vQmJuWElTZERBY1R2NG9BODdHN1dfZG1fZ1E3RVVsT2YyT1lSME9OZlk1bnhoVmxrMmF1TmNUcEwtc0N3WUhxV2lrdlNTcXRiTmtEMXpSa1RHc3YyMks1SklPZlQ1WUFWOE9kZ1pBU2h0VFI5Mjd2aW1pbkZpbw?oc=5","date":"2025-07-22","type":"deal","source":"PR Newswire","summary":"UPSHER-SMITH AND PARENT COMPANY BORA PHARMACEUTICALS HOST IOWA GOVERNOR KIM REYNOLDS TO DISCUSS U.S. SUPPLY CHAIN AND REGIONAL COLLABORATION - PR Newswire","headline":"UPSHER-SMITH AND PARENT COMPANY BORA PHARMACEUTICALS HOST IOWA GOVERNOR KIM REYNOLDS TO DISCUSS U.S. SUPPLY CHAIN AND RE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxON2VfTHp4bUdMc21aWFpQQ2tzQVVoUEttV3NQVndUWWltMVdsMG5tcFR6ajN2WnZmZ3k5dmRCOE1DaV9Ka1g5Zm1JWVYyUGt2MVo4OWJOQUg5Wnl3ZFUyQmJVbS02MWxDRXN3Z1hFMDBzRXRwN0lxMlhFTHNoaFBUd0Q3a3J1TmVuaS1MRGh5Y3ZzejlxaDc3RkZJemR2VFd2NTlicjY3ZmlLWkN1Ny1XbGpsMm1teTRzcnc?oc=5","date":"2025-07-22","type":"pipeline","source":"Contract Pharma","summary":"Upsher-Smith Hosts Iowa Governor for Roundtable Discussion & Facility Tour - Contract Pharma","headline":"Upsher-Smith Hosts Iowa Governor for Roundtable Discussion & Facility Tour","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBBMFdSejZuYWs0R05KV0V4WmpVWkU3RU5IVU44VVFUVjBQbnY5TDFQSk1sb1dJRGw4WjdYdTJlRU41S09DWjZRWDZNcXY4Zl8zazYtTUZlVXVWWUJnRTdn?oc=5","date":"2025-02-07","type":"pipeline","source":"Star Tribune","summary":"Pharma company Upsher-Smith to close Plymouth facility, lay off at least 58 workers - Star Tribune","headline":"Pharma company Upsher-Smith to close Plymouth facility, lay off at least 58 workers","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}